Logo ActuIA ActuIA

AI news from France

Français Español Italiano Deutsch Nederlands Română Polski Português العربية Türkçe Українська 中文 日本語 한국어
Publish
Home
AI Watch

By category

Funding Mergers & acquisitions Model release Product launch Partnership Public program / call for projects Regulation & governance Litigation Research & science Deployment & adoption Infrastructure & compute Corporate & strategy Security & incident Report & study Event

By sector

Company Culture Defense Education Finance Fundamental Research Health - medicine Industry Insurance Justice Marketing Media Risk Prevention Social networks Telecommunications Transport

By category

Funding Mergers & acquisitions Model release Product launch Partnership Public program / call for projects Regulation & governance Litigation Research & science Deployment & adoption Infrastructure & compute Corporate & strategy Security & incident Report & study Event

By sector

Company Culture Defense Education Finance Fundamental Research Health - medicine Industry Insurance Justice Marketing Media Risk Prevention Social networks Telecommunications Transport
Latest news
Language

Maximilien Levesque

Individu

2 articles liés à cet acteur

Aqemia raises €30 million to accelerate large-scale drug discovery

Aqemia raises €30 million to accelerate large-scale drug discovery

Aqemia announced on October 19 that it had raised €30 million in a Series A financing round co-led by Eurazeo and Bpifrance via its Large Venture fund...

Oct 21, 2022 Read more →
HealthTech 2021 Awards: France Biotech unveils the winning companies

HealthTech 2021 Awards: France Biotech unveils the winning companies

France Biotech, an association of health innovation entrepreneurs, unveiled the 7 companies awarded this year at the HealthTech 2021 awards ceremony...

Oct 22, 2021 Read more →
Logo ActuIA Logo ActuIA

Your source of information on artificial intelligence and its advances.

Navigation

  • Legal notice
  • Contact

Follow us

© 2019-2026 Net Square Digital. All rights reserved.